Occuity seeks to develop revolutionary non-invasive screening and monitoring devices for chronic diseases like diabetes and Alzheimer's. It argues that its device safely shines a low power beam of light into the eye and then collects and analyses the return signal to accurately measure structures within the eye and detect changes associated with the onset of the aforementioned diseases. Occuity is targeting three distinct markets, namely Ophthalmology, Disease Screening and Disease Monitoring, which is worth an estimated $35 billion per year. It claims that its 'Occuity Indigo' product enables earlier detection of diabetes and provides a non-contacting, pain-free glucose monitor. Occuity was awarded over £1.5 million as part of the Innovate UK grant for the development of technology within Occuity Indigo. It has also signed a partnership with one of the UK's leading ophthalmic distributors, Birmingham Optical, to distribute its PM1 pachymeter device. It states it will use 42% of the investment towards Research and Development (R&D), 23% towards sales and marketing, 20% towards management and finance, 9% towards managing CAPEX and NRE, and 6% towards paying fees.
Log in to view target
£12,857,589
pre-money valuation
12.28%
equity available
884
investors
£3,229
pledge per investor
12192959
company number
Active
company status
06/09/2019
incorporated 5 years
Previous Funding rounds
21 Apr 24 | Seedrs | £2,854,857 / 159% |
News
Berkshire's Occuity secures £1.3M investment to help product launches - The Business Magazine
12/12/2023 The Business Magazine
Occuity raises £1.3m 'to harness eye as window into body health' - BusinessCloud
12/12/2023 BusinessCloud
Occuity announces oculomics patent milestones - Optician Online
06/12/2023 Optician Online
Occuity secures UK and European distribution - aop.org.uk
14/07/2023 aop.org.uk
Occuity ramps up IP for early detection of diseases through the eye - Longevity.Technology
04/12/2023 Longevity.Technology
Reading's Occuity wins research contract for Alzheimer's screening device - The Business Magazine
21/03/2024 The Business Magazine
Occuity inks European partnerships for handheld ophthalmic device - Longevity.Technology
29/06/2023 Longevity.Technology
Occuity showcases PM1 Pachymeter - aop.org.uk
13/03/2023 aop.org.uk
Angels invest in Reading-based healthcare tech startup Occuity - The Business Magazine
08/06/2023 The Business Magazine
Occuity makes senior appointment - Optician Online
22/11/2021 Optician Online